Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
09/1996
09/25/1996EP0733048A1 Heterocyclic biphenylylamides useful as 5ht1d antagonists
09/25/1996EP0733046A1 Novel benzoyl guanidines, their production and their use in medicaments
09/25/1996EP0732934A1 Long-acting injection suspensions and a process for their preparation
09/25/1996EP0732933A1 Method of treating renal disease by administering igf-i and igfbp-3
09/25/1996EP0732932A1 Use of urinastatin-like compounds to prevent premature delivery
09/25/1996EP0732875A1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5)
09/25/1996CN1131666A Tricyclic pyrazole derivatives
09/25/1996CN1131546A Vaginal antiphlogistic powder and its preparation method
09/24/1996US5559153 Antiarrhythmia agents; cardiovascular disorders
09/24/1996US5559111 δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides
09/24/1996CA2046533C Treatment of endometriosis
09/24/1996CA2026418C Polypeptides useful as blockers of calcium channels
09/22/1996CA2172211A1 Treatment and prevention of prostatic cancer
09/19/1996WO1996028467A1 Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition
09/19/1996WO1996028403A1 SUBSTITUTED DIBENZ[a,f]AZULENES AND METHODS OF PREPARATION
09/19/1996WO1996028175A1 Immunomodulating compositions from bile for the treatment of immune system disorders
09/19/1996WO1996028155A1 Novel benzothiophene pharmaceutical compounds
09/19/1996WO1996028154A2 Use of anti-oestrogens as male contraceptives
09/19/1996WO1996028152A1 Novel benzofuran pharmaceutical compounds
09/19/1996WO1996028146A1 Novel naphthyl pharmaceutical compounds
09/19/1996WO1996028145A1 Use of nitric oxide donors or nitric oxide inhibitors for regulating cervical dilatation and extensibility
09/19/1996WO1996028142A1 Method and kit for preventing erectile dysfunction
09/19/1996WO1996021463A3 New applications of lysozyme dimer
09/19/1996DE19510862A1 Verwendung von Antiestrogenen zur männlichen Fertilitätskontrolle Use of antiestrogens for male birth control
09/19/1996CA2215373A1 Use of antiestrogens for male birth control
09/19/1996CA2215307A1 Pharmaceutical compositions and kits for preventing erectile dysfunction
09/19/1996CA2214779A1 Use of nitric oxide donor and/or substrate for inducing cervical dilation
09/19/1996CA2214450A1 Novel benzofuran pharmaceutical compounds
09/19/1996CA2214416A1 Novel naphthyl pharmaceutical compounds
09/19/1996CA2214261A1 Novel benzothiophene pharmaceutical compounds
09/18/1996EP0732329A1 Chroman derivative
09/18/1996EP0732101A1 Use of L-deprenyl for retarding age dependent deterioration of the immune system function in mammals
09/18/1996EP0731811A1 Chaperonin 10
09/18/1996EP0731790A1 Tachykinin antagonists
09/18/1996EP0731789A1 Dp-iv-serine protease inhibitors
09/18/1996EP0731787A1 Crystalline, polymorphic form of (s,s,s)-n-(1- 2-carboxy-3-(n?2 -mesyllysylamino)propyl]-1-cyclopentylcarbonyl)tyrosine
09/18/1996EP0731711A1 Dialysis fluid containing peptides obtained from casein as osmotic agents and bicarbonate ions as buffering agents
09/18/1996CN1131391A Use of thiazolidinedione derivatives and related antihyperglycemic agents in treatment of disease states at risk for progressing to non-insulin-dependent diabetes mellitus
09/18/1996CN1131158A Steroids with 17-spiromethylene lactone or lactol group
09/18/1996CN1131024A Traditional Chinese medicine preparation for curing tubal obstruction
09/18/1996CN1032787C Synergistic treatment method
09/17/1996US5556983 Phenylimidazolidines
09/17/1996US5556981 Angiotensin II antagonist intermediates
09/17/1996US5556845 11-β substituted-19-nor steroids
09/17/1996US5556753 DNA encoding human α1 adrenegric receptors and uses thereof
09/12/1996WO1996027658A1 Stimulation of meiosis
09/12/1996WO1996027593A1 Arginine analogues having nitric oxide synthase inhibitor activity
09/12/1996WO1996027386A1 Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
09/12/1996WO1996027375A2 Use of dextromethorphan or dextrorphan for the treatment of urinary incontinence
09/12/1996WO1996027372A1 Water-based topical cream containing nitroglycerin; method of preparation and use thereof
09/12/1996WO1996027292A1 Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria
09/12/1996CA2214723A1 Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria
09/12/1996CA2214126A1 Stimulation of meiosis
09/11/1996EP0731101A1 3-Benzyl-benzothiophenes
09/11/1996EP0731100A1 Benzothiophene pharmaceutical compounds
09/11/1996EP0731098A1 Alpha-substituted-3-benzyl-benzofurans
09/11/1996EP0731097A1 Novel benzofuran pharmaceutical compounds
09/11/1996EP0731093A1 Naphthyl pharmaceutical compounds
09/11/1996EP0730657A1 Composition for the in vivo production of therapeutic products
09/11/1996EP0730589A1 Isoxazoline compounds useful as fibrinogen receptor antagonists
09/11/1996EP0730448A1 Treatment of uterine contractility disorders with a nitric oxide synthase substrate and/or donor, or a nitric oxide inhibitor
09/11/1996EP0730445A1 Treatment of climacteric disorders with nitric oxide synthase substrates and/or donors
09/11/1996CN1130626A Adhesion receptor antagonists
09/11/1996CA2171404A1 3-benzyl-benzothiophenes
09/11/1996CA2171403A1 .alpha. substituted-1-benzyl-naphthyls
09/11/1996CA2171399A1 Substituted-3-benzyl-benzofurans
09/10/1996US5554642 Arylalkyl(thio) amides
09/10/1996US5554628 Method for minimizing the uterothrophic effect of tamoxifen and tamoxifen analogs
09/10/1996US5554604 Method of controlling male fertility
09/10/1996US5554600 Methods for inhibiting endometriosis
09/10/1996US5554593 Therapeutic agent for threatened abortion
09/06/1996WO1996026935A1 2-benzyl-3-arylbenzothiophenes
09/06/1996WO1996026932A1 2-arylbenzazole compounds
09/06/1996WO1996026727A1 Methods of inhibiting ovarian cancer
09/06/1996WO1996016981A3 Peptide compounds for prevention and/or treatment of no-mediated diseases
09/06/1996CA2214134A1 2-benzyl-3-arylbenzothiophenes
09/06/1996CA2214080A1 Methods of inhibiting ovarian cancer
09/04/1996EP0729964A1 Phosphorous-containing benzothiophenes
09/04/1996EP0729956A1 Benzothiophene compounds, intermediates, compositions, and methods
09/04/1996EP0729955A1 2-Benzyl-3-Arylbenzothiophenes useful for the treatment of post-menopausal syndrome
09/04/1996EP0729951A1 Naphthyl compounds, intermediates, compositions, and methods
09/04/1996EP0729758A2 Pyrazolopyrimidines and pyrrolopyrimidines for treatment of neuronal and other disorders
09/04/1996EP0729755A2 2-Phenyl-3-aroylbenziothiophenen for inhibiting ovarian cancer
09/04/1996EP0729472A1 Piperidinylcamphorsulfonyl oxytocin antagonists
09/04/1996EP0729356A1 Use of nitric oxide synthase inhibitors in the treatment of autoimmune diseases
09/04/1996CN1130063A Estogen effect promoting medicine
09/03/1996US5552444 Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes, 3-aminochromanes, and 3-aminothiochromanes
09/03/1996US5552417 Preventing premature sexual maturity, benzothiophene derivatives
09/03/1996US5552416 Methods of inhibiting dysfunctional uterine bleeding
09/03/1996US5552404 Compounds for neurotransmitters for animals
09/03/1996US5552403 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
09/03/1996US5552401 2-benzyl-3-arylbenzothiophenes
09/03/1996US5552150 Compostions containing di-linoleoyl-mono-gamma-linolenyl-glycerol
08/1996
08/29/1996WO1996026195A1 Benzothiazine dioxides as endothelin antagonists
08/29/1996WO1996025936A1 2,6-diaryl pyridazinones with immunosuppressant activity
08/29/1996CA2213192A1 Alpha.1a. adrenergic receptor antagonists
08/29/1996CA2213135A1 2,6-diaryl pyridazinones with immunosuppressant activity
08/29/1996CA2211027A1 Benzothiazine dioxides as endothelin antagonists
08/29/1996CA2170337A1 Naphthyl compounds, intermediates, compositions, and methods
08/29/1996CA2169414A1 Phosphorous-containing benzothiophenes